US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.40

-17.9900-6.70%

Post-market: 251.981.58+0.63%19:59 EDT

Volume:325.61K

Turnover:81.61M

Market Cap:494.41M

PE:- -

High:267.90

Open:266.14

Low:243.24

Close:268.39

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.30

T/O Rate:16.49%

Dividend:1.00

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Nestmedic’s PregnaOne 510(k) Moves Into Substantive FDA Review

Sector Update: Healthcare

MT Newswires Live

Health Care Roundup: Market Talk

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Rocket Pharmaceuticals: FDA Alignment De-Risks Danon Program, Safety Data Strengthens Outlook as Buy Rating Reiterated with Unchanged $15 Price Target

JLL Income Property Trust Expands Healthcare Real Estate Portfolio

Alignment Healthcare says not changing guidance

Alignment Healthcare not commenting on CMS Plan Preview 2

Alignment Healthcare shares drop 12.7% after speaking at Baird conference

Alignment Healthcare: ‘Don’t confuse integrity of business model’ with ST noise

OS Therapies announces full alignment on UK authorization application

Alignment Healthcare falls -11.7%

Sector Update: Healthcare

MT Newswires Live

GE Healthcare Technologies Launches CareIntellect Software to Streamline Hospital Operations

MT Newswires Live

Quantum BioPharma Showcases FDA-Backed Lucid-MS Program at Toronto Growth Summit

Analysts Have Conflicting Sentiments on These Healthcare Companies: SanBio Co (OtherSNBIF), Immutep Ltd (OtherPRRUF) and Inventiva (IVA)

Rocket Pharma Shares Climb Premarket After FDA Supports Continuation of Trial

Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application

Waystar Rises Over 16% Pre-Market as Report Says Healthcare Software Company Exploring Options Including Sale

Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":250.4,"timestamp":1789502400000,"preClose":268.39,"halted":0,"volume":325606,"hourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"delay":0,"changeRate":-0.0670293230001117,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Not Yet Opened","change":-17.99,"latestTime":"09-15 16:00:00 EDT","open":266.14,"high":267.9,"low":243.2444,"amount":81609965.98544,"amplitude":0.091865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":268.39,"sharesOutstanding":3074486,"nav":268.659,"aum":530464172.89,"dividendRate":0.004,"bidAskSpread":0.003539,"preHourTrading":{"tag":"盘前","latestPrice":267.7,"preClose":268.39,"latestTime":"09:25 EDT","volume":476,"amount":126913.024,"timestamp":1789478754552,"change":-0.69,"changeRate":-0.002571,"amplitude":0.027721},"postHourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"volumeRatio":1.297319,"impliedVol":0.9273,"impliedVolPercentile":0.568},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.297319,"shares":1974486,"dividePrice":1.0016,"high":267.9,"amplitude":0.091865,"preClose":268.39,"low":243.2444,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.4,"eps":0,"divideRate":0.004,"volume":325606,"delay":0,"ttmEps":0,"open":266.14,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":293.07,"twentyDayClose":287.3,"sixtyDayClose":206.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667629626","title":"Nestmedic’s PregnaOne 510(k) Moves Into Substantive FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629626","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629626?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:17","pubTimestamp":1789492658,"startTime":"0","endTime":"0","summary":"Nestmedic SA ( ($PL:NST) ) has provided an update. Nestmedic has moved to a new phase in its U.S. regulatory push, as the Food and Drug Administrat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nestmedics-pregnaone-510k-moves-into-substantive-fda-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nestmedics-pregnaone-510k-moves-into-substantive-fda-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629828","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629828","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629828?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:05","pubTimestamp":1789491915,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Tuesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each increasing about 0.1%.The iShares Biotechnology ETF  was down 1%.In corporate news, GSK  agreed to acquire global rights to an experimental T-cell engager therapy for multiple myeloma from Chinese biotechnology company Chimagen Biosciences in a deal worth up to $750 million, as the UK drugmaker aims to strengthen its blood cancer treatment portfolio. GSK shares were up 0.1%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSKH","HCSG","BK4588","BK4585","BK4532","LABU","LU0029874061.USD","IBB","LU1829250122.USD","XBI","BK4007","BK4581","BK4137","GSK","LU0128526141.USD","GSK.UK","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667933626","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2667933626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667933626?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:20","pubTimestamp":1789489200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0607 ET - AstraZeneca has a robust and diverse portfolio, with s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","XBI","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["BK4585","IDNA","MEDI","GNMX","TECB","XLVX","FRTY","TBXU","LABU","XBIX","IBB","RSPH","GDOC","IYH","MRNY","PSCH","SYNB","BMED","PINK","BK4588","NVIB","BBP","LFSC","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625562","title":"Rocket Pharmaceuticals: FDA Alignment De-Risks Danon Program, Safety Data Strengthens Outlook as Buy Rating Reiterated with Unchanged $15 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625562","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625562?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485326,"startTime":"0","endTime":"0","summary":"In a report released today, Yun Zhong from Wedbush maintained a Buy rating on Rocket Pharmaceuticals, with a price target of $15.00. Yun Zhong has ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rocket-pharmaceuticals-fda-alignment-de-risks-danon-program-safety-data-strengthens-outlook-as-buy-rating-reiterated-with-unchanged-15-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rocket-pharmaceuticals-fda-alignment-de-risks-danon-program-safety-data-strengthens-outlook-as-buy-rating-reiterated-with-unchanged-15-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625577","title":"JLL Income Property Trust Expands Healthcare Real Estate Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625577","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625577?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:12","pubTimestamp":1789485177,"startTime":"0","endTime":"0","summary":"An update from Jones Lang LaSalle Income Property Trust Inc Class I-A ( ($ZIPIAX) ) is now available. On September 14, 2026, JLL Income Property Tr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jll-income-property-trust-expands-healthcare-real-estate-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jll-income-property-trust-expands-healthcare-real-estate-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4588","BK4585","LABU","LU0029874061.USD","XBI","LU0054578231.USD","BK4581","BK4137","BK4079","JLL","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628238","title":"Alignment Healthcare says not changing guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628238?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:20","pubTimestamp":1789482016,"startTime":"0","endTime":"0","summary":"10:15 EDT Alignment Healthcare (ALHC) says not changing guidance Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-says-not-changing-guidance-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-says-not-changing-guidance-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4154","XBI","BK4539","BK4585","BK4581","XLV","ALHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628412","title":"Alignment Healthcare not commenting on CMS Plan Preview 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628412","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628412?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:15","pubTimestamp":1789481742,"startTime":"0","endTime":"0","summary":"Says cannot talk about CMS Plan Preview 2 “at all from a regulatory point of view.” Says “not happy” about HEI decisioning, “particularly that that...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-not-commenting-on-cms-plan-preview-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-not-commenting-on-cms-plan-preview-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","XBI","BK4154","BK4585","ALHC","LABU","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667362840","title":"Alignment Healthcare shares drop 12.7% after speaking at Baird conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667362840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667362840?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:15","pubTimestamp":1789481738,"startTime":"0","endTime":"0","summary":"10:12 EDT Alignment Healthcare (ALHC) shares drop 12.7% after speaking at Baird conference Published first on TheFly – the ultimate source for real...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-shares-drop-12-7-after-speaking-at-baird-conference-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-shares-drop-12-7-after-speaking-at-baird-conference-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4154","LABU","BK4588","BK4539","ALHC","BK4581","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628479","title":"Alignment Healthcare: ‘Don’t confuse integrity of business model’ with ST noise","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628479?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:15","pubTimestamp":1789481726,"startTime":"0","endTime":"0","summary":"10:13 EDT Alignment Healthcare (ALHC): ‘Don’t confuse integrity of business model’ with ST noise Published first on TheFly – the ultimate source fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-dont-confuse-integrity-of-business-model-with-st-noise-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-dont-confuse-integrity-of-business-model-with-st-noise-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4096","BK4588","BK4539","LU1861214812.USD","LU1861219969.SGD","ST","ALHC","XLV","LABU","BK4585","BK4154","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667162841","title":"OS Therapies announces full alignment on UK authorization application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667162841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667162841?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:10","pubTimestamp":1789481410,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced that it has achieved full alignment with the U.K. Medicines and Healthcare products Regulatory Agency on its pending ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-full-alignment-on-uk-authorization-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-full-alignment-on-uk-authorization-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","XBI","LABU","BK4139","BK4585","XLV","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628476","title":"Alignment Healthcare falls -11.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628476?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:05","pubTimestamp":1789481138,"startTime":"0","endTime":"0","summary":"Alignment Healthcare (ALHC) is down -11.7%, or -$1.51 to $11.43. Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-falls-11-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-falls-11-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","ALHC","BK4539","XBI","BK4588","LABU","BK4585","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667647921","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2667647921","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667647921?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:56","pubTimestamp":1789477008,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  up 0.1% and the iShares Biotechnology ETF  0.5% lower.Ascendis Pharma  will regain exclusive rights to certain drug treatments for metabolic and cardiovascular diseases, including obesity, having terminated a 2024 collaboration deal with Novo Nordisk , the company said. Shares of Ascendis Pharma were down less than 3% premarket.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","ASND","MEDI","BK4007","OZEM","IE00BKVL7J92.USD","BK4139","PPH","BK4532","BK4581","BK4585","XLV","LU0320765992.SGD","LU1093756325.SGD","THNR","IE00BZ1G4Q59.USD","BK4599","IBB","LU0109394709.USD","NVOH","NVO","XBI","LU0889565916.HKD","NVOX","LU0154236417.USD","NVOC","LU1093756168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667464791","title":"GE Healthcare Technologies Launches CareIntellect Software to Streamline Hospital Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2667464791","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667464791?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:56","pubTimestamp":1789476985,"startTime":"0","endTime":"0","summary":"GE Healthcare Technologies  has launched CareIntellect for Operations, a cloud-based software intended to support hospital administrators in managing patient flow and staffing, the company said Tuesday.The technology can help hospitals respond to changing conditions and improve the use of existing resources. By analyzing data on patient admissions, bed availability, and transfers, among others, the system can help streamline patient discharges and reduce wait times, the company said.The Queen's Health Systems in Hawaii and Duke Health in North Carolina will be the first health systems to implement the application, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","LU0128526141.USD","BK4082","HCSG","XBI","LU0689626769.HKD","XLV","LU0124676726.USD","LGHT","LU0029874061.USD","GEHC","BK4585","LABU","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642019","title":"Quantum BioPharma Showcases FDA-Backed Lucid-MS Program at Toronto Growth Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642019?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:32","pubTimestamp":1789475529,"startTime":"0","endTime":"0","summary":"Quantum Biopharma ( ($QNTM) ) just unveiled an update. On September 15, 2026, Quantum BioPharma announced it will participate in the 3rd Annual Arc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quantum-biopharma-showcases-fda-backed-lucid-ms-program-at-toronto-growth-summit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quantum-biopharma-showcases-fda-backed-lucid-ms-program-at-toronto-growth-summit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4555","LCIZ","BK4551","LCDL","BK4596","LABU","BK4585","LCID","BK4588","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667964295","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: SanBio Co (OtherSNBIF), Immutep Ltd (OtherPRRUF) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667964295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667964295?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:20","pubTimestamp":1789474816,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on SanBio Co (SNBIF), Immutep Ltd (PRRUF) and Inventi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sanbio-co-othersnbif-immutep-ltd-otherprruf-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sanbio-co-othersnbif-immutep-ltd-otherprruf-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV","XBI","SNBIF","BK4581","BK4585","LABU","BK4137","LU0128526141.USD","BK4588","BK4139","PRRUF","LU0029874061.USD","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642146","title":"Rocket Pharma Shares Climb Premarket After FDA Supports Continuation of Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642146","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642146?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:19","pubTimestamp":1789474740,"startTime":"0","endTime":"0","summary":"Rocket Pharmaceuticals' shares jumped ahead of the opening bell after the biotechnology company said it was aligned with the Food and Drug Administration on the path forward for its pivotal phase 2 tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCKT","BK4139","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667264291","title":"Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667264291","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667264291?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:10","pubTimestamp":1789474252,"startTime":"0","endTime":"0","summary":"Cogent Biosciences (COGT) announced that the FDA has accepted its new drug application for bezuclastinib in patients with Advanced Systemic Mastocy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cogent-biosciences-reports-fda-acceptance-of-bezuclastinib-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cogent-biosciences-reports-fda-acceptance-of-bezuclastinib-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4532","LABU","LFSC","CCOI","LU1670627923.USD","LU1670628061.USD","BK4588","CANC","BK4505","BK4089","COGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667120642","title":"Waystar Rises Over 16% Pre-Market as Report Says Healthcare Software Company Exploring Options Including Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2667120642","media":"TradingKey","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667120642?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:01","pubTimestamp":1789473708,"startTime":"0","endTime":"0","summary":"TradingKey - On September 15 ET, shares of healthcare software company Waystar (WAY) rose more than 16% at one point in pre-market trading.","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20260915/way-ed88a225d5a64f4c80b8b10fa1df2086.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260915/way-ed88a225d5a64f4c80b8b10fa1df2086.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262168582-waystar-way-us-ipo-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU0128526141.USD","LU2089283258.USD","LU1074936037.SGD","BK4588","BK4516","LU1169590202.USD","LU1244550221.USD","LU1162221912.USD","LU1244550494.USD","LU2023251221.USD","LU2357305700.SGD","LU0557290698.USD","LU1989772923.USD","LU0225283273.USD","LU2264538146.SGD","LU0882574139.USD","IE00B775SV38.USD","LU2347655156.SGD","LU0106831901.USD","IE00B3S45H60.SGD","LU0053666078.USD","BK4504","LU1988902786.USD","KBWB","LU0267386448.USD","LU2111349929.HKD","LU1732799900.SGD","LU0098860793.USD","LU2133065610.SGD","HCSG","QQH","LU0390134368.USD","LU0528227936.USD","LU1064131342.USD","XLV","LU0158827948.USD","BK4585","IAI","WAY","LABU","LU1720051017.SGD","BK4534","LU1668664300.SGD","LU0971096721.USD","LU2487616109.SGD","LU1548497426.USD","BK4127","LU2089284900.SGD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667422886","title":"Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667422886","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667422886?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSM PDUFA target action date set for","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3361988/0/en/cogent-biosciences-announces-fda-acceptance-of-new-drug-application-nda-for-bezuclastinib-in-patients-with-advanced-systemic-mastocytosis-advsm.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2931357623.SGD","LABU","BK4585","BK4532","AEIS","LU1815336091.USD","IE0031619046.USD","IE00B66KJ199.SGD","LU2089985449.USD","IE00B7SZL793.SGD","LU1670627923.USD","IE00B19Z4B17.USD","CCOI","LU1670628061.USD","LU0757428866.USD","BK4588","BK4089","LU0274383776.USD","BK4157"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":2,"totalSize":425,"code":"91000000","status":"200"}]}}